Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$601M |
| 2 |
Parker-Hannifin
PH
|
+$576M |
| 3 |
JPMorgan Chase
JPM
|
+$575M |
| 4 |
Goldman Sachs
GS
|
+$452M |
| 5 |
FedEx
FDX
|
+$371M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$733M |
| 2 |
American Tower
AMT
|
+$684M |
| 3 |
Nike
NKE
|
+$601M |
| 4 |
AGN
Allergan plc
AGN
|
+$561M |
| 5 |
McDonald's
MCD
|
+$536M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Consumer Discretionary | 17.46% |
| 3 | Healthcare | 13.37% |
| 4 | Communication Services | 12.12% |
| 5 | Financials | 11.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OKS
401
DELISTED
Oneok Partners LP
OKS
| $21.9M | 0.02% |
509,589
+25,382
| +5% | +$1.05M |
|
402
MaxLinear
MXL
$5.35B
| $21.6M | 0.02% |
989,176
+117,943
| +14% | +$2.44M |
|
403
Cadence Design Systems
CDNS
$95.1B
| $21.5M | 0.02% |
852,526
-95,927
| -10% | -$2.47M |
|
|
ROIC
404
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $20.9M | 0.02% |
988,156
+20,676
| +2% | +$424K |
|
|
ARIA
405
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $20.7M | 0.02% |
+1,660,288
| New | +$20M |
|
406
CNX Resources
CNX
$4.84B
| $20.6M | 0.02% |
1,357,806
-87,318
| -6% | -$1.38M |
|
|
YDKN
407
DELISTED
Yadkin Financial Corporation
YDKN
| $20.5M | 0.02% |
597,227
+8,286
| +1% | +$252K |
|
408
Prothena Corp
PRTA
$448M
| $20.1M | 0.02% |
409,582
+1,675
| +0.4% | +$92.4K |
|
|
CLVS
409
DELISTED
Clovis Oncology, Inc.
CLVS
| $20M | 0.02% |
450,247
+29,517
| +7% | +$1.04M |
|
410
HDFC Bank
HDB
$121B
| $19.8M | 0.02% |
1,302,656
+30,544
| +2% | +$511K |
|
411
Celanese
CE
$4.77B
| $19.8M | 0.02% |
250,841
+43,214
| +21% | +$3.25M |
|
|
POT
412
DELISTED
Potash Corp Of Saskatchewan
POT
| $19.7M | 0.02% |
1,089,626
-78,754
| -7% | -$1.36M |
|
|
NSTG
413
DELISTED
NanoString Technologies, Inc.
NSTG
| $19.1M | 0.02% |
+857,954
| New | +$18.4M |
|
414
CALL
Eli Lilly
LLY
$1.09T
| $19.1M | 0.02% |
260,000
+130,000
| +100% | +$9.68M |
|
|
CIM
415
Chimera Investment
CIM
$1.06B
| $18.8M | 0.02% |
367,531
| – | – |
|
|
DBVT
416
DBV Technologies
DBVT
$799M
| $18.8M | 0.02% |
53,415
+109
| +0.2% | +$39.1K |
|
417
Prestige Consumer Healthcare
PBH
$2.45B
| $18.6M | 0.02% |
356,363
-185,943
| -34% | -$8.97M |
|
|
INXN
418
DELISTED
Interxion Holding N.V.
INXN
| $18.5M | 0.02% |
527,274
+8,549
| +2% | +$304K |
|
|
CALD
419
DELISTED
Callidus Software, Inc.
CALD
| $18.4M | 0.02% |
1,097,898
+15,799
| +1% | +$270K |
|
|
PINC
420
DELISTED
Premier
PINC
| $18.3M | 0.02% |
603,884
-227,651
| -27% | -$7.01M |
|
|
STKL
421
DELISTED
SunOpta
STKL
| $18.3M | 0.02% |
2,589,883
-823,546
| -24% | -$5.73M |
|
422
Wheaton Precious Metals
WPM
$49.8B
| $18.1M | 0.02% |
934,516
-61,981
| -6% | -$1.29M |
|
423
MarketAxess Holdings
MKTX
$4.34B
| $18M | 0.02% |
122,795
+53,371
| +77% | +$8.48M |
|
|
TMH
424
DELISTED
Team Health Holdings Inc
TMH
| $17.9M | 0.02% |
412,095
-242,298
| -37% | -$10M |
|
|
WPZ
425
DELISTED
Williams Partners L.P.
WPZ
| $17.8M | 0.02% |
469,090
+202,288
| +76% | +$7.27M |
|
Similar funds
Jennison Associates's Q4 2016 Portfolio in Review
As of Q4 2016, Jennison Associates held 857 positions worth $89.6B, down 3.4% from $92.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Jennison Associates withdrew a net $3.76B in Q4 2016, closing 52 positions and reducing 313 holdings. Its most notable exit was lululemon athletica, an estimated $342M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Parker-Hannifin worth $606M.
- Jennison Associates's largest Q4 2016 buy was Parker-Hannifin: 4,330,276 shares worth $606M.
- Jennison Associates added most to Charter Communications in Q4 2016, an estimated $601M increase.
- Jennison Associates's biggest Q4 2016 reduction was Biogen, cutting an estimated $733M.
- Jennison Associates fully exited lululemon athletica in Q4 2016, selling an estimated $342M.
- Jennison Associates's ten largest holdings make up 25% of its $89.6B portfolio in Q4 2016.
- Jennison Associates opened 208 new positions and closed 52 in Q4 2016.
- Jennison Associates's portfolio value fell 3.4% quarter-over-quarter to $89.6B.
Based on Jennison Associates's 13F filing for Q4 2016, filed 6 Feb 2017.